News & Updates

OSA, anaemia show synergistic effect on hypertension

Anaemia and obstructive sleep apnoea (OSA) appear to have a combined impact on the incidence of hypertension, suggests a study.

Skin fairness creams not fair to the kidneys

A recent review integrates multiple research findings and turns the spotlight on the growing nephrotoxic threat posed by skin-whitening creams.

IBD patients at increased risk of intrahepatic cholestasis of pregnancy

Pregnant women with inflammatory bowel disease (IBD), especially those with thiopurine exposure, face a heightened risk of intrahepatic cholestasis of pregnancy (ICP), according to the results of a systematic review and meta-analysis.

Remibrutinib improves sleep, daily activities in patients with CSU

Treatment with remibrutinib, an oral, highly selective Bruton’s tyrosine kinase inhibitor, improved sleep and daily activities in patients with chronic spontaneous urticaria (CSU), according to two phase III REMIX-1 and -2 studies presented at AAD 2025.

Postpartum depression risk may be lower among mothers with medically assisted pregnancies

Mothers who conceived after medically assisted reproduction interventions appear to be less likely to have postpartum depression compared with those who conceived spontaneously, as suggested in a study.

A quarter of Singaporean youths engage in self-harm

For every four young people in Singapore, one has a history of nonsuicidal self-injury (NSSI), as shown in a study.

Sacubitril-valsartan a boon to hypertension patients with ESKD on dialysis

Treatment with sacubitril-valsartan (SV) demonstrates good tolerability and may provide some benefits to hypertension patients with end-stage kidney disease (ESKD) who are undergoing dialysis, as shown by the results of a recent meta-analysis.

Apremilast boasts long-term improvement in PPP

Patients with palmoplantar pustulosis (PPP) treated with apremilast show improvements at week 16, with continued treatment resulting in maintained or further improvement at week 52, according to a study presented at AAD 2025. No new safety concerns have been observed.

How to optimize treatment strategies for mHSPC by integrating pivotal data?